Lean Body Mass and Side Effects in Patients With Lymphoma
NCT ID: NCT04698616
Last Updated: 2021-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
141 participants
OBSERVATIONAL
2020-02-09
2021-03-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
STAY-STRONG Study of Exercise Training During Chemotherapy
NCT05556239
Treatment of Localized Low Grade Lymphomas
NCT00536458
Danish Elder Lymphoma Patient Hematopoietic Investigation
NCT05245487
Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9
NCT00400907
Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma
NCT01715961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Malignant lymphoma patients
Identification of the patients who are/are not dose-reduced due to chemotherapy, and then look at the body composition in connection with this.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Legal of age
Exclusion Criteria
* People who cannot speak and understand Danish
* Pregnant and breastfeeding
* Dementia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jens Rikardt Andersen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jens Rikardt Andersen
Sponsor - Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jens R Andersen, MD,MPA
Role: STUDY_CHAIR
University of Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Copenhagen
Copenhagen, Frederiksberg, Denmark
Sjællands Universitetshospital, Hæmatologisk Afdeling H60
Roskilde, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SJ-823
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.